"A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial RX for Positive Node, Endocrine Responsive Breast Cancer"
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital
Study ID
Protocol Number: UCH11-1079
More information available at ClinicalTrials.gov: NCT01272037
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers